STOCKHOLMS LAENS LANDSTING - Sweden 

Ranking results:

Past rankings:

2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:600-700
Total Number of Projects:68
Total Project Funding:600-700
Networking Rank (Reputation):700-800
Networking Rank (Reputation):700-800
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
Total Project Funding:800-900
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2007
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 13
As coordinator: 0
As participant: 13
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2016 0 4.811.998 1.067.062 1
2015 0 6.397.077 1.451.217 1
2014 0 4.000.000 400.000 1
2013 0 28.002.205 996.757 3
2012 0 17.948.458 1.302.843 3
2011 0 14.679.049 186.431 3
2010 0 1.155.363 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
KAROLINSKA INSTITUTE4
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
REGION HOVEDSTADEN3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
KUNGLIGA TEKNISKA HOEGSKOLAN2
LUNDS UNIVERSITET2
SKANE LANS LANDSTING2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS2
THE CHRISTIE NHS FOUNDATION TRUST2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITY COLLEGE LONDON HOSPITALSNHS FOUNDATION TRUST2
ACCON GMBH INGENIEURBUERO FUER SCHALL UND SCHWINGUNGSTECHNIK1
ADAPTIMMUNE LIMITED1
AKRON NV1
ALEXANDER DENNIS LIMITED1
AMSTERDAM BIOTHERAPEUTICS UNIT1
AMSTERDAM MOLECULAR THERAPEUTICS BV1
ANAGNOSTICS BIOANALYSIS1
ASSOCIATION EUROPEENNE POUR LA MALADIE DE PARKINSON1
ASSTRA ASSOCIAZIONE TRASPORTI1
AZIENDA PER LA MOBILITA DEL COMUNE DI ROMA1
BAYER PHARMA1
BIOARCTIC NEUROSCIENCE AB1
BIOTEST1
BLEKINGE LANS LANDSTING1
CELLULAR THERAPEUTICS LIMITED1
CONSORZIO ITALIANO PER LA RICERCA IN MEDICINA1
CYSTIC FIBROSIS EUROPE EV1
D'APPOLONIA1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
DIGNA BIOTECH SL1
DRK BLUTSPENDEDIENST BADEN WURTTEMBERG HESSEN GGMBH1
DYNAMICS STRUCTURES AND SYSTEMS INTERNATIONAL1
ENDESA1
ENIDE SOLUTIONS SL1
EUROPEAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY1
FACHHOCHSCHULE LANDSHUTUNIVERSITYOF APPLIED SCIENCES1
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA1
GILUPI1
GRUPO MECANICA DEL VUELO SISTEMAS S A1
HACETTEPE UNIVERSITESI1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG1
HELMUT BERENDS1
HUNTINGDON LIFE SCIENCES1
IDIADA AUTOMOTIVE TECHNOLOGY1
IKERLAN SCOOP1
IMMUN SYSTEM IMS AB1
IMOSS NV1
INMUNOTEK SL1
INSTITUT CATALA DE LA SALUT1
INSTITUT FUER PHOTONISCHE TECHNOLOGIEN EV1
INSTITUT GUSTAVE ROUSSY1
INTERUNIVERSITAIR MICRO ELECTRONICA CENTRUM VZW1
IRIZAR S COOP1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KIINTEISTO OY LAITILAN TERVEYSKOTI1
KING'S COLLEGE HOSPITAL NHS TRUST1
KLINIKUM BREMERHAVENREINKENHEIDE GGMBH1
LARIX AS1
LIFE SCIENCE GOVERNANCE INSTITUTE1
LIFEGLIMMER1
LYTIX BIOPHARMA AS1
MARSDEN DOREEN1
MICROFLUIDIC CHIPSHOP1
MILTENYI BIOTEC1
MTR STOCKHOLM AB1
MUKOVISZIDOSE INSTITUT GEMEINNUETZIGE GESELLSCHAFT FUR FORSCHUNG UND THERAPIEENTWICKLUNG1
NEURONOVA AB1
NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY1
OSLO UNIVERSITETSSYKEHUS HF1
OSPEDALE SAN RAFFAELE1
PE INTERNATIONAL1
PHARMA CONSULTING GROUP IN UPPSALA AB1
PLZENSKA TEPLARENSKA AS1
PLZENSKE MESTSKE DOPRAVNI PODNIKY AS1
POLIS PROMOTION OF OPERATIONAL LINKS WITH INTEGRATED SERVICES ASSOCIATION INTERNATIONALE1
PROPHYLIX PHARMA AS1
RAY SEARCH LABORATORIES AB1
REGION MIDTJYLLAND1
REGION NORDJYLLAND1
REHAB STATION STOCKHOLM AKTIEBOLAG1
RHEINISCH WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN1
ROYAL FREE HOSPITAL ROYAL FREE HAMPSTEAD NHS TRUST1
SERVICIO MADRILENO DE SALUD1
SKODA ELECTRIC AS1
SOLARIS BUS & COACH1
SSE PLC1
STADTWERKE BONN VERKEHRSGMBH1
STADTWERKE MUNSTER1
STALLERGENES1
STICHTING ANTONI VAN LEEUWENHOEK ZIEKENHUIS1
STICHTING MAASTRICHT RADIATION ONCOLOGY ""MAASTRO CLINIC""1
STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC1
STOCKHOLMS UNIVERSITET1
STRATHCLYDE PARTNERSHIP FOR TRANSPORT1
STRUKTON RAIL AB1
TEL AVIV UNIVERSITY1

Constancy:

Total number of partners: 153
Partner loyalty:
Frequent Partner: (> 2 projects): 10
Rare Partner: 143
Frequent / Rare Partner Ratio: 0.07

Project overview:

Start dateProjectacronymrolefundingpartners
2016-11-01Connecting Patients and Carers using wearable sensor technology NIGHTINGALEparticipant4.811.9985
2015-01-01Regenerative treatment of complete Traumatic Spinal Cord injury with a surgical implantation of a biodegradable device with FGF1 and nerve grafts SC0806participant6.397.0776
2014-01-01A CANcer Development mOnitor CanDoparticipant4.000.00010
2013-11-01Zero Emission bUs Systems ZEEUSparticipant13.490.49940
2013-06-01Quiet Tracks for Sustainable Railway Infrastructures QUIET-TRACKparticipant2.598.11512
2013-01-01Improving Outcome of Necrotizing Fasciitis: Elucidation of Complex Host and Pathogen Signatures that Dictate Severity of Tissue Infection INFECTparticipant11.913.59115
2012-12-01Adoptive engineered T cell Trials to Achieve Cancer Killing ATTACKparticipant6.000.00016
2012-08-01Development of a prophylactic treatment for the prevention of fetal/neonatal alloimmune thrombocytopenia (FNAIT) PROFNAITparticipant5.986.00011
2012-01-01Phase II clinical trial of PDGF-BB for the neurological regeneration and recovery in Parkinson´s disease NRTparticipant5.962.45810
2011-04-01Adaptive and innovative Radiation Treatment FOR improving Cancer patients treatment outcomE ARTFORCEparticipant5.994.71514
2011-01-01Augmenting PBGD expression in the liver as a Novel Gene therapy for Acute Intermittent Porphyria AIPGENEparticipant3.308.1547
2011-01-01Immunoglobulin IgY pseudomonas A clinical trial for cystic fibrosis treatment IMPACTTparticipant5.376.18010
2010-09-01Viscogel - A chitosan based adjuvant for prophylactic and therapeutic vaccination ViVacparticipant1.155.36310